NIDA PROGRAM PROJECT CONSOLIDATED PROGRAM AND REVIEW GUIDELINES Release Date: August 26, 1999 National Institute on Drug Abuse PURPOSE The purpose of this notice is to inform the research community that the National Institute on Drug Abuse (NIDA) has clarified its program and review guidelines for Program Project grants (P01 mechanism). NIDA awards Program Project grants for research projects closely related to a central theme that can be conducted effectively and efficiently through a coordinated collaborative or multidisciplinary approach using common resources, facilities, and instruments. NIDA supports Program Projects of only the highest quality, and each research project within the P01 award must be supportable on its own merit. The scientific merit of each research project is assessed independently as well as within the context of the whole program. Program projects are expected to be broadly based investigative efforts with a well defined central focus or objective. The efforts should address critical issues of neuroscience, behavior, prevention, treatment, epidemiology, etiology, health services, or other drug abuse-related research areas. Applications will be accepted on an on-going basis. The receipt dates for all unsolicited center applications, whether new, competing renewal, or revised, are February 1, June 1, and October 1. An applicant requesting $500,000 or more in direct costs for any year of a center is required to obtain agreement from the Institute program staff that the Institute is willing to accept the application for review and possible funding. The name of the program contact must be indicated in a cover letter submitted with the application. Applications that do not identify a program contact will be returned to the applicant without review. These guidelines are effective with applications submitted for the February 1, 2000, receipt date. The Program Project Consolidated Program and Review Guidelines are available on NIDA's home page (http://www.nida.nih.gov/) and may be obtained from: National Institute on Drug Abuse Office of Extramural Program Review 6001 Executive Boulevard, Room 3158 Bethesda, MD 20892-9547 Telephone: (301) 443-2755 E-mail: jp86z@nih.gov Applications submitted under these guidelines must be sent to the Center for Scientific Review at the address noted in the application form PHS-398 (rev. 4/98).
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |